» Articles » PMID: 24627713

Interferences from Blood Collection Tube Components on Clinical Chemistry Assays

Overview
Specialty Biochemistry
Date 2014 Mar 15
PMID 24627713
Citations 95
Authors
Affiliations
Soon will be listed here.
Abstract

Improper design or use of blood collection devices can adversely affect the accuracy of laboratory test results. Vascular access devices, such as catheters and needles, exert shear forces during blood flow, which creates a predisposition to cell lysis. Components from blood collection tubes, such as stoppers, lubricants, surfactants, and separator gels, can leach into specimens and/or adsorb analytes from a specimen; special tube additives may also alter analyte stability. Because of these interactions with blood specimens, blood collection devices are a potential source of pre-analytical error in laboratory testing. Accurate laboratory testing requires an understanding of the complex interactions between collection devices and blood specimens. Manufacturers, vendors, and clinical laboratorians must consider the pre-analytical challenges in laboratory testing. Although other authors have described the effects of endogenous substances on clinical assay results, the effects/impact of blood collection tube additives and components have not been well systematically described or explained. This review aims to identify and describe blood collection tube additives and their components and the strategies used to minimize their effects on clinical chemistry assays.

Citing Articles

CODI: Enhancing machine learning-based molecular profiling through contextual out-of-distribution integration.

Eissa T, Huber M, Obermayer-Pietsch B, Linkohr B, Peters A, Fleischmann F PNAS Nexus. 2024; 3(10):pgae449.

PMID: 39440022 PMC: 11495219. DOI: 10.1093/pnasnexus/pgae449.


Multi-View Integrative Approach For Imputing Short-Chain Fatty Acids and Identifying Key factors predicting Blood SCFA.

Liu A, Tian B, Qiu C, Su K, Jiang L, Zhao C bioRxiv. 2024; .

PMID: 39386638 PMC: 11463355. DOI: 10.1101/2024.09.25.614767.


Impact of Preanalytical Procedures on Complement Biomarkers in Cerebrospinal Fluid and Plasma from Controls and Alzheimer's Disease Patients.

Gutierrez J, Kurz C, Sandoval C, Edmonds R, Bittner T, Perneczky R J Alzheimers Dis. 2024; 101(2):563-576.

PMID: 39213066 PMC: 11492022. DOI: 10.3233/JAD-240287.


Evaluation of a multiplex liquid chromatography-tandem mass spectrometry method for congenital adrenal hyperplasia in pediatric patients.

Cao J, Sonilal M, Roper S, Ali M, Devaraj S Clin Mass Spectrom. 2024; 9:18-22.

PMID: 39193353 PMC: 11322746. DOI: 10.1016/j.clinms.2018.07.001.


Generation of Rapid and High-Quality Serum by Recombinant Prothrombin Activator Ecarin (RAPClot™).

Zhao K, Dimeski G, Masci P, Johnson L, Wang J, de Jersey J Biomolecules. 2024; 14(6).

PMID: 38927049 PMC: 11201583. DOI: 10.3390/biom14060645.


References
1.
Chance J, Berube J, Vandersmissen M, Blanckaert N . Evaluation of the BD Vacutainer PST II blood collection tube for special chemistry analytes. Clin Chem Lab Med. 2009; 47(3):358-61. DOI: 10.1515/cclm.2009.072. View

2.
Borga O, Piafsky K, Nilsen O . Plasma protein binding of basic drugs. I. Selective displacement from alpha 1-acid glycoprotein by tris(2-butoxyethyl) phosphate. Clin Pharmacol Ther. 1977; 22(5 Pt 1):539-44. View

3.
Sevastos N, Theodossiades G, Efstathiou S, Papatheodoridis G, Manesis E, Archimandritis A . Pseudohyperkalemia in serum: the phenomenon and its clinical magnitude. J Lab Clin Med. 2006; 147(3):139-44. DOI: 10.1016/j.lab.2005.11.008. View

4.
Janknegt R, Lohman J, Hooymans P, Merkus F . Do evacuated blood collection tubes interfere with therapeutic drug monitoring?. Pharm Weekbl Sci. 1983; 5(6):287-90. DOI: 10.1007/BF02074856. View

5.
Bowen R, Hortin G, Csako G, Otanez O, Remaley A . Impact of blood collection devices on clinical chemistry assays. Clin Biochem. 2009; 43(1-2):4-25. DOI: 10.1016/j.clinbiochem.2009.10.001. View